Tanaka Akemi J, Bai Renkui, Cho Megan T, Anyane-Yeboa Kwame, Ahimaz Priyanka, Wilson Ashley L, Kendall Fran, Hay Beverly, Moss Timothy, Nardini Monica, Bauer Mislen, Retterer Kyle, Juusola Jane, Chung Wendy K
Department of Pediatrics, Columbia University Medical Center, New York, New York 10029, USA;
GeneDx, Gaithersburg, Maryland 20877, USA;
Cold Spring Harb Mol Case Stud. 2015 Oct;1(1):a000356. doi: 10.1101/mcs.a000356.
PURA is the leading candidate gene responsible for the developmental phenotype in the 5q31.3 microdeletion syndrome. De novo mutations in PURA were recently reported in 15 individuals with developmental features similar to the 5q31.3 microdeletion syndrome. Here we describe six unrelated children who were identified by clinical whole-exome sequencing (WES) to have novel de novo variants in PURA with a similar phenotype of hypotonia and developmental delay and frequently associated with seizures. The protein Purα (encoded by PURA) is involved in neuronal proliferation, dendrite maturation, and the transport of mRNA to translation sites during neuronal development. Mutations in PURA may alter normal brain development and impair neuronal function, leading to developmental delay and the seizures observed in patients with mutations in PURA.
PURA是导致5q31.3微缺失综合征发育表型的主要候选基因。最近报道了15例具有与5q31.3微缺失综合征相似发育特征的个体中存在PURA的新发突变。在此,我们描述了6名无关儿童,他们通过临床全外显子组测序(WES)被鉴定出在PURA中存在新的新发变异,具有肌张力减退和发育迟缓的相似表型,且经常伴有癫痫发作。蛋白质Purα(由PURA编码)参与神经元增殖、树突成熟以及神经元发育过程中mRNA向翻译位点的转运。PURA中的突变可能会改变正常的大脑发育并损害神经元功能,导致发育迟缓以及PURA突变患者中观察到的癫痫发作。